NEW YORK ( TheStreet) -- Meridian Bioscience (Nasdaq: VIVO) hit a new 52-week low Monday as it is currently trading at $15.48, below its previous 52-week low of $15.71 with 2,352 shares traded as of 9:30 a.m. ET. Average volume has been 342,100 shares over the past 30 days. Meridian Bioscience has a market cap of $666.3 million and is part of the health care sector and drugs industry. Shares are down 32% year to date as of the close of trading on Friday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. The company has a P/E ratio of 26.2, above the average drugs industry P/E ratio of 25.8 and above the S&P 500 P/E ratio of 17.7.
- Practice your VIVO trading strategies and win cash in our stock game.